Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

Incremental risk of prior coronary arterial stents for pulmonary resection.

Fernandez FG, Crabtree TD, Liu J, Meyers BF.

Ann Thorac Surg. 2013 Apr;95(4):1212-8; discussion 1219-20. doi: 10.1016/j.athoracsur.2013.01.042. Epub 2013 Mar 5.

PMID:
23465849
2.

Lung resection for non-small cell lung cancer after prophylactic coronary angioplasty and stenting: short- and long-term results.

Voltolini L, Rapicetta C, Luzzi L, Paladini P, Ghiribelli C, Scolletta S, Fineschi M, Gotti G.

Minerva Chir. 2012 Feb;67(1):77-85.

PMID:
22361679
3.

Short-term outcomes of balloon angioplasty versus stent placement for patients undergoing primary percutaneous coronary intervention: Implications for patients requiring early coronary artery bypass surgery.

Mehta RH, Harjai KJ, Boura JA, Tcheng JE, Dixon SR, Stone GW, Grines CL.

Am Heart J. 2013 Jun;165(6):1000-7. doi: 10.1016/j.ahj.2013.03.006. Epub 2013 Apr 18.

PMID:
23708173
5.

A multicenter randomized comparison of drug-eluting balloon plus bare-metal stent versus bare-metal stent versus drug-eluting stent in bifurcation lesions treated with a single-stenting technique: six-month angiographic and 12-month clinical results of the drug-eluting balloon in bifurcations trial.

Stella PR, Belkacemi A, Dubois C, Nathoe H, Dens J, Naber C, Adriaenssens T, van Belle E, Doevendans P, Agostoni P.

Catheter Cardiovasc Interv. 2012 Dec 1;80(7):1138-46. doi: 10.1002/ccd.23499. Epub 2012 Mar 15.

PMID:
22422607
6.

Perioperative in-stent thrombosis after lung resection performed within 3 months of coronary stenting.

Brichon PY, Boitet P, Dujon A, Mouroux J, Peillon C, Riquet M, Velly JF, Ris HB.

Eur J Cardiothorac Surg. 2006 Nov;30(5):793-6. Epub 2006 Sep 22.

PMID:
16996274
8.

Risk of major adverse cardiac events following noncardiac surgery in patients with coronary stents.

Hawn MT, Graham LA, Richman JS, Itani KM, Henderson WG, Maddox TM.

JAMA. 2013 Oct 9;310(14):1462-72. doi: 10.1001/jama.2013.278787. Erratum in: JAMA. 2014 Feb 5;311(5):528.

PMID:
24101118
9.

Choice of stenting strategy in true coronary artery bifurcation lesions.

Lin QF, Luo YK, Lin CG, Peng YF, Zhen XC, Chen LL.

Coron Artery Dis. 2010 Sep;21(6):345-51. doi: 10.1097/MCA.0b013e32833ce04c.

PMID:
20613498
10.

Five-year clinical follow-up of unprotected left main bifurcation lesion stenting: one-stent versus two-stent techniques versus double-kissing crush technique.

Chen SL, Zhang Y, Xu B, Ye F, Zhang J, Tian N, Liu Z, Qian X, Ding S, Li F, Zhang A, Liu Y, Lin S.

EuroIntervention. 2012 Nov 22;8(7):803-14. doi: 10.4244/EIJV8I7A123.

11.
13.

Perioperative Cardiovascular Risk of Prior Coronary Stent Implantation Among Patients Undergoing Noncardiac Surgery.

Mahmoud KD, Sanon S, Habermann EB, Lennon RJ, Thomsen KM, Wood DL, Zijlstra F, Frye RL, Holmes DR Jr.

J Am Coll Cardiol. 2016 Mar 8;67(9):1038-49. doi: 10.1016/j.jacc.2015.11.063.

14.

Should we recommend oral anticoagulation therapy in patients with atrial fibrillation undergoing coronary artery stenting with a high HAS-BLED bleeding risk score?

Ruiz-Nodar JM, Marín F, Roldán V, Valencia J, Manzano-Fernández S, Caballero L, Hurtado JA, Sogorb F, Valdés M, Lip GY.

Circ Cardiovasc Interv. 2012 Aug 1;5(4):459-66. doi: 10.1161/CIRCINTERVENTIONS.112.968792. Epub 2012 Jul 10.

15.

Comparison between one-stent versus two-stent technique for treatment of left main bifurcation lesions: A large single-center data.

Gao Z, Xu B, Yang Y, Qiao S, Wu Y, Chen T, Xu L, Yuan J, Chen J, Gao RL.

Catheter Cardiovasc Interv. 2015 Jun;85(7):1132-8. doi: 10.1002/ccd.25849. Epub 2015 Feb 18.

PMID:
25614097
16.

Can the optimal type of stent be predicted based on clinical risk factors? A subgroup analysis of the randomized BASKET-PROVE trial.

Vassalli G, Klersy C, De Servi S, Galatius S, Erne P, Eberli F, Rickli H, Hornig B, Bertel O, Bonetti P, Moccetti T, Kaiser C, Pfisterer M, Pedrazzini G; BASKET-PROVE Investigators..

Am Heart J. 2016 Mar;173:1-7. doi: 10.1016/j.ahj.2015.11.007. Epub 2015 Dec 1.

PMID:
26920590
17.

Catastrophic outcomes of noncardiac surgery soon after coronary stenting.

Kałuza GL, Joseph J, Lee JR, Raizner ME, Raizner AE.

J Am Coll Cardiol. 2000 Apr;35(5):1288-94.

18.

Very long-term results comparing a simple versus a complex stenting strategy in the treatment of coronary bifurcation lesions.

Sheiban I, Infantino VA, Colombo F, Bollati M, Omedè P, Moretti C, Sciuto F, Siliquini R, Chiadò S, Trevi GP, Biondi-Zoccai G.

Catheter Cardiovasc Interv. 2009 Aug 1;74(2):313-20. doi: 10.1002/ccd.22023.

PMID:
19496110
19.

Synergy between direct coronary stenting technique and use of the novel thin strut cobalt chromium Skylor™ stent: the MACE in follow up patients treated with Skylor stent [MILES Study].

Giordano A, Polimeno M, Corcione N, Fattore L, Di Lorenzo L, Biondi-Zoccai G, Ferraro P, Romano MF.

Curr Cardiol Rev. 2012 Feb;8(1):6-13.

20.

Comparison between the NERS (New Risk Stratification) score and the SYNTAX (Synergy between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery) score in outcome prediction for unprotected left main stenting.

Chen SL, Chen JP, Mintz G, Xu B, Kan J, Ye F, Zhang J, Sun X, Xu Y, Jiang Q, Zhang A, Stone GW.

JACC Cardiovasc Interv. 2010 Jun;3(6):632-41. doi: 10.1016/j.jcin.2010.04.006.

Supplemental Content

Support Center